Relationship of insulin resistance in chronic haemodialysis patients with inflammatory indicators, malnutrition, echocardiographic parameters and 24 hour ambulatory blood pressure monitoring

Scandinavian Journal of Urology and Nephrology

Volumn 44, Issue 4, 2010, Pages 257-264

  Kurat, Seyhun ^a   Colak, Hulya Bahadir ^a   Toraman, Aysun ^a   Tekçe, Hikmet ^a   Ulman, Cevval ^a   Bayturan, Ozgur ^a  

^a CELAL BAYAR UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Blood pressure; Haemodialysis; Inflammation; Insulin resistance

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; ECHOCARDIOGRAPHY; FEMALE; HEMODIALYSIS; HUMAN; HYPERTENSION; HYPERVOLEMIA; INFLAMMATION; INSULIN RESISTANCE; MALE; MALNUTRITION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; KIDNEY DISEASES; MALE; MALNUTRITION; MIDDLE AGED; RENAL DIALYSIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; VENA CAVA, INFERIOR;

EID: 77955544743     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.3109/00365591003733682     Document Type: Article

References (36)

1. Culleton BF, Larson MG,Wilson PW, Evans JC, Parfrey PS, Levy D. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 1999;56:2214-2219
2. Howard G, OLeary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, et al. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 1996;93:1809-1871.
3. Schmitz O, Alberti KG, Christensen NJ, Hasling C, Hjllund E, Beck-Nielsen H, et al. Aspects of glucose homeostasis in uremia as assessed by the hyperinsulinemic euglycemic clamp technique. Metabolism 1985;34: 465-473
4. Alvestrand A, Mujagic M, Wajngot A, Efendic S. Glucose intolerance in uremic patients. The relative contributions of impaired beta-cell function and insulin resistance. Clin Nephrol 1989;31:175-183
5. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, et al. Insulin resistance in essential hypertension. N Engl J Med 1987;317:350-357
6. Kanauchi M, Kimura K, Akai Y, Saito Y. Insulin resistance and pancreatic beta-cell function in patients with hypertensive kidney disease. Nephrol Dial Transplant 2004;19: 2025-2029
7. Kimmel PL, Peterson RA, Weihs KL, ShidlerN, Simmens SJ, Alleyne S, et al. Immunologic function and survival in haemodialysis patients. Kidney Int 1998;54:236-244
8. Bologa RM, Levine DM, Parker TS, Cheigh JS, Serur D, Stenzel KH, et al. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 1998;32:107-114
9. Mantzoros CS. The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med 1999;130:651-657
10. Auwerx J, Bouillon R, Collen D, Geboers J. Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus. Arteriosclerosis 1988;8:68-72.
11. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with endstage renal disease. J Am Soc Nephrol 2002;13:134-141
12. Kalantar-Zadeh K, Kleiner M, Dunne E, Lee GH, Luft FC. A modified quantitative subjective global assessment of nutrition for dialysis patients. Nephrol Dial Transplant 1999;14:1732-1738
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment. Diabetologia 1985;28:c412-9.
14. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki- Jrvinen H, Van Haeften T, et al. Use of oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000;23:295-301.
15. Yilmaz MI, Saglam M, Qureshi AR, Carrero JJ, Caglar K, Eyileten T, et al. Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin. Nephrol Dial Transplant 2008;23: 1621-1627
16. Huang JW, Yen CJ, Chiang HW, Hung KY, Tsai TJ, Wu KD. Adiponectin in peritoneal dialysis patients: a comparison with hemodialysis patients and subjects with normal renal function. Am J Kidney Dis 2004;43:1047-1055
17. Rasic-Milutinovic Z, Perunicić G, Pljesa S, Gluvić Z, Ilić M, Stokić E. The effect of nutritional status, body composition, inflammation and serum iron on the development of insulin resistance among patients on long-term hemodialysis. Med Pregl 2007;60(Suppl 2):33-38
18. Zoccali C, Tripepi G, Cambareri F, Catalano F, Finocchiaro P, Cutrupi S, et al. Adipose tissue cytokines, insulin sensitivity, inflammation, and cardiovascular outcomes in end-stage renal disease patients. J Ren Nutr 2005;15:125-130
19. Lee SW, Park GH, Lee SW, Song JH, Hong KC, Kim MJ. Insulin resistance and muscle wasting in non-diabetic endstage renal disease patients. Nephrol Dial Transplant 2007;22:2554-2562
20. Kaftan HA, Evrengul H, Tanriverdi H, Kilic M. Effect of insulin resistance on left ventricular structural changes in hypertensive patients. Int Heart J 2006;47:391-400.
21. Dzurik R, Spustova V, Janekova K. The prevalence of insulin resistance in kidney disease patients before the development of renal failure. Nephron 1995;69:281-285
22. Fliser D, Pacini G, Engelleiter R, Kautzky-Willer A, Prager R, Franek E, et al. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 1998;53:1343-1347
23. Chen J, Muntner P, Hamm LL, Fonseca V, Batuman V, Whelton PK, et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 2003;14:469-477
24. Shen DC, Shieh SM, Fuh MT, Wu DA, Chen YDI, Reaven GM. Resistance to insulin stimulated glucose uptake in patients with hypertension. J Clin Endocrinol Metab 1988;66:580-583
25. Denker PS, Pollock VE. Fasting serum insulin levels in essential hypertension: a meta-analysis. Arch Intern Med 1992;152:1649-1651
26. Sarafidis PA, Bakris GL. The antinatriuretic effect of insulin: an unappreciated mechanism for hypertension associated with insulin resistance? Am J Nephrol 2007;27:44-54.
27. Rowe JW, Young JB, Minaker KL, Stephens AL, Pallotta J, Landsberg L. Effects of insulin and glucose infusions on sympathetic nervous activity in normal man. Diabetes 1981;30:219-225
28. Pfeile B, Dischaneit H. Effects of insulin on growth of cultured arterial smooth muscle cells. Diabetologia 1981;20:155-158
29. De Fronzo RA. The effect of insulin on renal sodium metabolism: a review with clinical implications. Diabetologia 1981;21:161-171
30. London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, et al. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: followup of an interventional study. J Am Soc Nephrol 2001;12: 2759-2767
31. Anan F, Takahashi N, OoIe T, Yufu K, Saikawa T, Yoshimatsu H. Role of insulin resistance in nondipper essential hypertensive patients. Hypertens Res 2003;26:669-676
32. Chen JW, Jen SL, Lee WL, Hsu NW, Lin SJ, Ting CT, et al. Differential glucose tolerance in dipper and nondipper essential hypertension: the implications of circadian blood pressure regulation on glucose tolerance in hypertension. Diabetes Care 1998;21:1743-1748
33. Venkatesan J, Henrich WL. Anemia, hypertension, and myocardial dysfunction in end-stage renal disease. Am J Kidney Dis 1997;17:257-269
34. Stenvinkel P. Inflammation in end-stage renal failure: could it be treated? Nephrol Dial Transplant 2002;17:33-38
35. Vischer UM, Safar ME, Safar H, Iaria P, Le Dudal K, Henry O, et al. Cardiometabolic determinants of mortality in a geriatric population: is there a "reverse metabolic syndrome"? Diabetes Metab 2009;35:108-114
36. Kürsat S, Teke H, Ekmeki C, Colak HB, Alici T. Relationship between the degree of malnutrition and echocardiographic parameters in hemodialysis patients. Nephron Clin Pract 2007;106:36-42.